Prof. Liu graduated from the School of Public Health, Peking University Health Science Center in 2005. He received a Ph.D degree from Institute of Microbiology, Chinese Academy of Sciences in 2010 and had the postdoctoral training at Yale School of Medicine. The main research focus of his group is the epitope-specific T-cell recognition of emerging and re-emerging viruses, i.e. influenza viruses, coronaviruses, etc. He has published more than 190 papers in English journals such as Nature (×2), Immunity, PNAS, Nat Commun, EID, CID, JID, J Virol (×10) and J Immunol (×9), etc. He is the Assistant Secretary of Asia-Pacific Biosafety Association (A-PBA), the deputy Editor-in-Chief of Biosafety and Health. During the 2014-16 Ebola epidemic in West Africa, he worked as one specialist in the first Public Health Team from China to support Africa and also the team leader for the Ebola test in P3 Laboratory in West Africa for nine months. He also worked as the team leader of the first Chinese Public Health Team to the Democratic Republic of the Congo during the Ebola epidemic from June to July, 2018. During the COVID-19 pandemic, he worked onsite in difference outbreaks for the emergency responses.
Jun Liu
